Your GLP-1 Helps Drive Weight Loss.
Which Secretagogue Helps You Keep What You Earned?

A secretagogue is a signal, not a supply. Instead of injecting growth hormone itself, these peptides signal your pituitary gland to release more of your body's own natural growth hormone, in the pulsatile pattern your body already uses, with the feedback loop intact. Sermorelin and tesamorelin are GHRH analogs. CJC-1295/Ipamorelin pairs a GHRH analog with a ghrelin mimetic for a dual-pathway signal. All three are prescription medications; sermorelin and CJC-1295/Ipamorelin are compounded, and compounded medications are not FDA-approved.

You don't have to — that's the provider's job. The short version: sermorelin is the gentle, well-documented starting signal (sleep, recovery, lean-mass baseline). CJC-1295/Ipamorelin is the stronger, longer dual-pathway signal. Tesamorelin is the body-composition specialist with visceral-fat trial data. Which one fits depends on your goals, training, health history, and current medications — which is exactly what the $0 eligibility review evaluates.

That is the combination this page is about: one medication supporting weight loss, and one provider-reviewed pathway that may support lean tissue, recovery, and sleep quality. They act on different pathways. Whether the combination is appropriate for you depends on your health history, current medications, and contraindications, which is what the provider review is for. Never combine prescription medications without a clinician's guidance.

Taking growth hormone means injecting exogenous GH, which supplies the hormone directly and can suppress your body's own production through negative feedback. Secretagogues work upstream: they signal your pituitary to release your own GH, in pulses, with the feedback loop intact. Because secretagogues work upstream, growth-hormone release remains subject to the body's normal feedback pathways. For patients looking to discuss lean-tissue support, recovery, and sleep quality, that upstream route is the mechanism our providers review for appropriateness.

Many patients tolerate these protocols well, but side effects and contraindications vary by molecule and medical history. The most commonly reported effects across the class are mild injection-site reactions, flushing, or headache. CJC-1295/Ipamorelin may also cause temporary water retention, tingling, or increased hunger in some patients. Tesamorelin may cause injection-site reactions, joint aches, or tingling, and can affect blood sugar, which your provider considers when reviewing your history. The provider review exists precisely to screen for contraindications and determine whether any of these is appropriate for you; this is not a decision to crowdsource from a forum.

Because "for research purposes only" means "not for human use." Unknown purity. Unknown dosing. No clinician if something goes wrong. No recourse if the vial is garbage. You of all people know that an unverified input makes the whole system unreliable. This program exists so you never have to roll those dice: a licensed provider, a licensed U.S. pharmacy, and a real medical record.